DOPPS Special Issue Slide Presentations

PowerPoint™ slides supporting research articles published. The DOPPS encourages use of these slides by the health care community and other researchers.

To view the slides, you need to have Microsoft® Powerpoint Viewer. To download the free version, click here. Then click the "Powerpoint Viewer" link.

The notes field to these slides may contain source information or additional detail. To view these notes, which are not available in an online browser, save the Microsoft® PowerPoint™ file to your computer and open in PowerPoint ("normal" or "notes page" view).

1	Anemia
	Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns Study., Port FK, et al. Anemia management outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Pisoni RL, et al. Erythropoetin therapy in Europe: Results from the DOPPS, Pisoni RL, et al. Anaemia and associated morbidity and mortality among haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Locatelli F, et al. Anemia Management for Hemodialysis Patients: K/DOQI Guidelines and DOPPS Findings, Locatelli F, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis treatment practices in the United States, Port FK, et al. Mineral metabolism predictors of hemoglobin concentration among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)., Kimata N, et al.
2	Comorbidity
	Anaemia and associated morbidity and mortality among haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Locatelli F, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Goodkin DA, et al.
3	Depression
	Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe, Lopes AA, et al. Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS, Lopes AA, et al.
4	Dialysis Dose
	Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns Study., Port FK, et al. High dialysis dose is associated with lower mortality among women but not among men, Port FK, et al. Dose of Dialysis: Key Lessons from Major Observational Studies and Clinical Trials, Saran R, et al.
5	Hospitalization
	Early readmission and length of hospitalization practices in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Lopes AA, et al. Anemia Management for Hemodialysis Patients: K/DOQI Guidelines and DOPPS Findings, Locatelli F, et al. Mortality and hospitalisation in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Rayner HC, et al. Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPS, Saran R, et al. Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS), Mapes DL, et al.
6	KDOQI
	Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns Study., Port FK, et al. The Dialysis Outcomes and Practice Patterns Study and the Kidney Disease Outcomes Quality Initiative: A Cooperative Initiative to Improve Outcomes for Hemodialysis Patients Worldwide, Port FK, et al. K/DOQI and the DOPPS: Nutrition Guidelines, Indicators, and Practices, Combe CH, et al.
7	Medications
	Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS)., Bailie GR, et al. DOPPS Data on Medications in Hemodialysis Patients, Andreucci VE, et al. Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for under-prescription, Bailie GR, et al. Erythropoetin therapy in Europe: Results from the DOPPS, Pisoni RL, et al. HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients, Mason NA, et al. International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Fissell RB, et al. Association between vascular access failure and the use of specific drugs: The Dialysis Outcomes and Practice Patterns Study (DOPPS), Saran R, et al.
8	Methods
	The Dialysis Outcomes and Practice Patterns Study: Design, Data Elements, and Methodology, Pisoni RL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study, Young EW, et al. Random sample (DOPPS) versus census-based registry approaches to kidney disease research., Port FK, et al.
9	Mineral Metabolism
	Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns Study., Port FK, et al. Mineral metabolism predictors of hemoglobin concentration among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)., Kimata N, et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study, Young EW, et al. Magnitude and Impact of Abnormal Mineral Metabolism in Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study, Young EW, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis treatment practices in the United States, Port FK, et al.
10	Mortality
	Mortality Risk for Patients Receiving Hemodiafiltration versus Hemodialysis: European Results from the DOPPS, Canaud B, et al. Factors Associated with “Do Not Resuscitate” Orders and Rates of Withdrawal from Hemodialysis in the International DOPPS, Fissell RB, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS, Fissell RB, et al. Mortality Among Hemodialysis Patients in Europe, Japan, and the United States: Case-Mix Effects, Goodkin DA, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Bommer J, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS, Burdick RA, et al. Anaemia and associated morbidity and mortality among haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Locatelli F, et al. Anemia Management for Hemodialysis Patients: K/DOQI Guidelines and DOPPS Findings, Locatelli F, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Goodkin DA, et al. High dialysis dose is associated with lower mortality among women but not among men, Port FK, et al. Dose of Dialysis: Key Lessons from Major Observational Studies and Clinical Trials, Saran R, et al. Mortality and hospitalisation in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Rayner HC, et al. HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients, Mason NA, et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study, Young EW, et al. Magnitude and Impact of Abnormal Mineral Metabolism in Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study, Young EW, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis treatment practices in the United States, Port FK, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe, Lopes AA, et al. Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPS, Saran R, et al. International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Fissell RB, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS, Pifer TB, et al. Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Leavey SF, et al. Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS), Mapes DL, et al.
11	Nutrition
	K/DOQI and the DOPPS: Nutrition Guidelines, Indicators, and Practices, Combe CH, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis treatment practices in the United States, Port FK, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS, Pifer TB, et al. Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Leavey SF, et al. Haemodialysis prescription, adherence, and nutritional indicators in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Hecking E, et al.
12	Prescription
	Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS), Bailie GR, et al. Haemodialysis prescription, adherence, and nutritional indicators in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)., Hecking E, et al.
13	Quality of Life
	Health-Related Quality of Life in the DOPPS, Mapes D, et al. Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study, Lopes AA, et al. Health-related quality of life among dialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study, Fukuhara S, et al. Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS, Lopes AA, et al. Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS), Mapes DL, et al.
14	Transplant
	Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS), Satayathum S, et al.
15	Vascular Access
	Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns Study., Port FK, et al. Timing of first cannulation and vascular access failure in haemodialysis: An analysis of practice patterns at dialysis facilities in the DOPPS, Saran R, et al. Vascular Access Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): Performance Against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines, Rayner HC, et al. Creation, cannulation and survival of arterio-venous fistulae: Data from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Rayner HC, et al. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Young EW, et al. Vascular access use in Europe and the United States: Results from the DOPPS., Pisoni RL, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis treatment practices in the United States, Port FK, et al. Association between vascular access failure and the use of specific drugs: The Dialysis Outcomes and Practice Patterns Study (DOPPS), Saran R, et al.

The DOPPS is an observational hemodialysis study collecting detailed information on over 15,000 patients in over 300 dialysis facilities from 12 countries around the world.